Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-23-010806

Options or other derivatives

  • Director acquired 8,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
LEFF JONATHAN S Director 2023-05-09 Grant or award · Stock Option (Right to Buy) +8,300 8,300 D: show line 1 in the form
Loading xslF345X04/form4.xml…